Viewing Study NCT06230679



Ignite Creation Date: 2024-05-06 @ 8:03 PM
Last Modification Date: 2024-10-26 @ 3:19 PM
Study NCT ID: NCT06230679
Status: RECRUITING
Last Update Posted: 2024-05-16
First Post: 2024-01-19

Brief Title: Effectiveness of NESA in the Treatment of Cancer Survivors
Sponsor: Aníbal Báez Suárez
Organization: University of Las Palmas de Gran Canaria

Study Overview

Official Title: Effectiveness of NESA in the Treatment of Sleep Problems Fatigue and Neuromuscular Pain in Cancer Survivors
Status: RECRUITING
Status Verified Date: 2024-08
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: Cancer is a disease or a set of diseases that increased in our society However improvements in their detection and treatment increase the number of patients who survive Every year 26 million people are diagnosed in the European Union and 14 million become cancer survivors However these people suffer the late adverse effects of treatment that can seriously affect their quality of life

the most common late effects are pain fatigue and sleeping difficulties These are estimated between 58-90 The autonomic nervous system ANS appears to play an important role in the manifestation and perpetuation of these symptoms
Detailed Description: This study aims to evaluate NESA or NESA non-invasive neuromodulation to treat the most common long-term side effects in cancer survivors due to the most used treatments

It will be compared between two groups of cancer survivors The intervention group with electrical stimulation and the sham group without electrical stimulation emission The subjects will be assigned randomly Neither the patient the therapist nor the analystsresearchers will know the assignment

Finally this project aims to add a passive tool to the therapeutic arsenal of health professionals in the oncology field for the treatment of late side effects

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None